Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South
University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive
medicine at the University of South China
· Professional training at Huazhong University
of Science and Technology and Tongji
Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
Repeated fetal arrest for test tube, repeated abortion for test tube country selection, third generation test tube PGT-A, which country is better for test tube baby, overseas test tube cost, test tube success rate, test tube with abnormal chromosome, test tube selection for elderly people, Kyrgyz test tube, Malaysian test tube, and American test tube.
Which country is more suitable for repeated fetal arrest to do test tubes? Analysis on the Differences and Selection Logic of Different National Schemes
First, why do you often consider changing countries for "repeated fetal arrest"?
From the medical essence, repeated fetal arrest is not a "luck problem", but a screening ability problem.
The core reasons can be divided into three categories:
Chromosome abnormality (most important)
Immune or coagulation factors
Uterine environmental problems
Among them, clinical data show that:
About 90% of fetal arrest is related to chromosomal abnormalities in embryos.
With the increase of age, the abnormal probability increases obviously (over 40 years old)
This means:
If there is no "embryo screening ability", multiple transplants may fail repeatedly.
2. What are the essential differences of test tubes in different countries?
Many people ask "which country is good", but the essence is not the country, but:
Can we do "embryo screening+individualization scheme"
The following is disassembled in a structured way.
1 Technical layer differences (core)
Types can solve problems.
First-generation/second-generation in vitro fertilization
Screening for Chromosome Abnormalities in the Third Generation Test Tube (PGT-A)
Three generations+immune management for repeated fetal arrest
For people with repeated fetal arrest:
The key point is not whether to do test tubes, but whether to do the third generation screening.
2 Different countries' strategic differences
America (technology-oriented)
PGT-A is mature in application.
Individualized scheme is meticulous
Suitable for complex cases
Suitable for:
Multiple fetal arrest
Old age (≥38 years old)
History of chromosome abnormality
Malaysia/Thailand (cost-effective orientation)
Mature technology (supporting PGT-A)
The cost is relatively controllable.
Flexible cycle arrangement
Suitable for:
There are budget constraints.
Want to do screening but not pursue the ultimate medical resources.
Kyrgyzstan/CIS (process efficiency oriented)
Fast cycle and short waiting time
The scheme is relatively concentrated.
Attention has increased in recent years.
Suitable for:
Want to enter the cycle quickly after many failures
Time-cost sensitive population
Mexico (policy+screening combination)
Support the third generation screening.
The process is more flexible
There are more international patients
Some people think that:
PGT-A screening is a key breakthrough for people with recurrent fetal arrest.
Third, what is the difference in success rate?
Many people are most concerned about the success rate, but they need to correct a cognitive misunderstanding:
The success rate is not determined by the state, but by "crowd+technology matching"
Reference data:
The overall success rate of mainstream reproductive centers is about 40%-60%
The optimization center can reach about 60%
But the point is:
For "people with repeated fetal arrest"
If PGT screening is done:
The core source of single success rate improvement = embryo quality screening, not the country.
Four, people with repeated fetal arrest, choose four key standards of the country.
① whether the third generation test tube (PGT-A/PGT-M) is supported?
This is the core, no one.
(2) whether we can do "individualized assessment"
Including:
Immune index
Coagulation function
Intima receptivity
③ Laboratory level (determining embryo quality)
Including:
Blastocyst culture ability
Embryo screening technology
④ Cycle efficiency (ignored by many people)
Whether to queue up or not
Can you enter the cycle quickly?
V. Common misunderstandings
Myth 1: Changing countries can solve problems.
If you don't solve the essential problem (chromosome/immunity), it's the same everywhere.
Myth 2: Just look at the price.
Low price ≠ screening ability
People with fetal arrest need more "screening ability"
Myth 3: only look at the success rate publicity
Success rate must be combined with:
age
cause of a disease
Embryo number
VI. Questions and answers
Q1: Do I have to do three generations of test tubes for repeated fetal arrest?
Not necessarily, but if chromosome problems or old age are involved, the third generation test tube is more meaningful.
Q2: Will it be successful to go abroad after repeated fetal arrest?
I can't. Success depends on:
Is the embryo normal?
Does the uterine environment match?
Q3: Why do many people have test tubes or fetal arrest?
Because:
Only the first/second generation test tubes were made.
No screening for embryonic abnormalities
Q4: Which countries should be given priority for repeated fetal arrest?
Logical order:
Technology priority → USA
Cost performance → Malaysia/Thailand
Cycle efficiency → Kyrgyzstan
Q5: Can you make a test tube once?
Not necessarily.
The essence of test tube is to "improve the probability", not to guarantee the result.
VII. Summary
Core conclusion:
The key problem of repeated fetal arrest is: embryo quality (chromosome)
The country is not the core variable, but the technology and screening ability.
The third generation test tube (PGT) is of great significance to this population.
Common aliases:Kyrgyzstan Tulip Reproductive Center, Tulip IVF, Tulip Reproductive Center, Tulip Hospital, Kyrgyz Tulip Reproductive Center, Kyrgyz Tulip Hospital
